PAA

2.38%

20.5¢ pharmaust limited

Ann: Prospectus, page-15

First 15 Last

Share
Profile

Follow
NZ Trader

11,821 Posts.

5988

08/11/16

14:18

Post #: 20452418
Share

Originally posted by Mickey Mouse ↑

With the raising of working capital now at 5 cps, that gives all shareholders who are in for the long haul to have the opportunity to help the company and those who don't to sell out.

PAA needs the four or five million to see us over the mark for our trials, and to put runs on the board. The company has managed to overcome the main hurdle which was the taste of PPL1 and we now have our second lot of canine trials underway. Indeed we need more funds to get us over the line and especially to list on NASDAQ. They have very stringent rules allowing a company to list and PAA can and will pass them and we will list.

With regards to being fully underwritten in the USA, PAA must get its share price up and we must be able to show runs on the board.

A major point that is being over looked, is the pure and simple fact, is that when PAA is able to demonstrate with the current canine trials being run now and in the future, is that NOVATIS ANIMAL HEALTH can exercise its option in PAA. I am of the understanding that would mean that they will give us an amount of money to make this run and progress at a much faster pace. In the long term PAA would receive income from NOVATIS ANIMAL HEALTH under licence as a royalty for PAA.

Finally I believe that the most important part about the canine trials, is when they show regression and or stability in cancers in canines that there would have to be somewhere I would guess upwards of an 80% chance that we could move forwards in the treatment of humans with PPL1.

There are exciting time ahead for PAA, with todays announcement for raising capital a big step in the right direction for this company to suceed and progress well in the years to come.

Watch this space

All the best
MM

Expand

where does it say this is enough to get the company over the line? I think the CR was at to low a rate but the market will demonstrate over the next day.

PAA Price at posting: 5.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

ASX hits all time high out the gate on Friday trades following bullish US inflation data

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

There are more pages in this discussion • 21 more messages in this thread...

First 15 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 20.5¢		Change -0.005(2.38%)		Mkt cap ! $91.22M

Open	High	Low	Value	Volume
21.5¢	21.5¢	20.5¢	$174.5K	841.9K

Buyers (Bids)

No.	Vol.	Price($)
10	458470	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
21.0¢	144453	3

View Market Depth

No.	Vol.	Price($)
9	443470	0.200
7	254593	0.195
12	529478	0.190
23	1020957	0.185
16	883831	0.180

Price($)	Vol.	No.
0.210	144453	3
0.215	166899	3
0.220	149118	3
0.230	51179	1
0.240	25634	1

Last trade - 16.10pm 12/07/2024 (20 minute delay)

PAA (ASX) Chart

Ann: Prospectus, page-15

Immutep reports strong response rate from immunotherapies treating carcinomas

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Prospectus, page-15

Top Stories

Immutep reports strong response rate from immunotherapies treating carcinomas

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News